Screener
Praxis Precision Medicines, Inc. PRAX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -38.9%+22.1pp | -35.3%+28.2pp | -45.8%+25.2pp | -75.2%-10.9pp | -61%-13.8pp | |
| Return on invested capital | -67.9%+36.1pp | -62.2%+69.5pp | -86.8%— | -143.2%— | -103.9%— | |
| Liquidity | ||||||
| Current ratio | 15.7×+9.4× | 15.9×+7.4× | 10.2×-0.5× | 5.2×-5.8× | 6.3×-11.0× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $46.03+145% | $48.82+134% | $39.02+56.9% | $15.63-22.9% | $18.82-15.5% | |
| Valuation | ||||||
| Market capitalization | $8.9B+770% | $8.97B+1,075% | $7.37B+414% | $1.12B+9.2% | $895.42M+26.5% | |
| Price / book | 6.6×+4.1× | 6.4×+4.6× | 8.4×+5.2× | 3.2×+0.6× | 2.2×+0.5× |
FAQ
- Where do Praxis Precision Medicines, Inc.'s ratios come from?
- Every ratio is computed from Praxis Precision Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.